Translate this page into:
Flagellate erythema: A rare presentation of idiopathic dermatomyositis
Corresponding author: Prof. Hae Young Choi, Department of Dermatology, Ewha Womans University College of Medicine, Yangcheon-gu, Seoul, Korea. hychoi@ewha.ac.kr
-
Received: ,
Accepted: ,
How to cite this article: Choi J, Lee JJ, Byun JY, Choi HY. Flagellate erythema: A rare presentation of idiopathic dermatomyositis. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_553_2024
Dear Editor,
Flagellate erythema is a distinctive type of cutaneous eruption characterised by the sudden onset of parallel, linear or curvilinear plaques, typically on the trunk, resembling whiplash marks. Originally identified as related to bleomycin toxicity,1 it can also be associated with the consumption of undercooked shiitake mushrooms and less commonly with rheumatological diseases and various chemotherapy drugs.2 We report a rare case of flagellate erythema associated with idiopathic dermatomyositis.
A 43-year-old man treated with tenofovir for hepatitis B and liver cirrhosis presented to our hospital with severe pruritic red-to-purple parallel streaks and acute proximal muscle weakness that began a month earlier. He reported owning a cat and using vegetable cat litter but denied consumption of mushrooms or use of bleomycin.
Physical examination revealed persistent erythematous parallel streaks on the trunk, accompanied by the shawl sign, the V sign and confluent patches on the buttocks [Figures 1a and 1b]. In addition, Holster sign [Figure 1c] and Gottron’s papules were present, along with a heliotrope rash and periorbital oedema. Serum biochemistry revealed elevated levels of creatine kinase (8108 IU/L), aspartate aminotransferase (344 IU/L), alanine aminotransferase (151 IU/L) and lactate dehydrogenase (863 IU/L). Antinuclear antibody was weakly positive, whereas other autoantibodies, including the anti-Jo-1 antibody, were negative. A skin biopsy of a violaceous parallel streak from the lower back showed interface dermatitis and superficial dermal perivascular lymphoplasmacytic infiltration [Figures 2a and 2b]. T2-weighted fat-suppressed magnetic resonance imaging of the hips revealed symmetrical bilateral muscle hyperintensities of the buttocks and thighs. Muscle biopsy revealed muscle fibre necrosis with regeneration and minimal inflammation. These findings were consistent with those for dermatomyositis. Additional studies, including colonoscopy and abdominal computed tomography, did not show signs of occult tumours. The patient was diagnosed with idiopathic dermatomyositis and treated with systemic corticosteroids (methylprednisolone, 62.5 mg/day), azathioprine and methotrexate. Following 3 months of treatment, the cutaneous and muscular symptoms resolved and the patient is currently receiving maintenance therapy with azathioprine and methotrexate.
![Flagellated streaks accompanied by shawl sign, and confluent patches on the buttocks with crusts on the upper back.](/content/126/2024/0/1/img/IJDVL_553_2024-g1.png)
- Flagellated streaks accompanied by shawl sign, and confluent patches on the buttocks with crusts on the upper back.
![Flagellated streaks accompanied by V sign on the neck.](/content/126/2024/0/1/img/IJDVL_553_2024-g2.png)
- Flagellated streaks accompanied by V sign on the neck.
![Erythematous patch on the lateral aspect of the thigh (Holster sign).](/content/126/2024/0/1/img/IJDVL_553_2024-g3.png)
- Erythematous patch on the lateral aspect of the thigh (Holster sign).
![Skin biopsy showing atrophic epidermis (Haematoxylin & eosin, 40x).](/content/126/2024/0/1/img/IJDVL_553_2024-g4.png)
- Skin biopsy showing atrophic epidermis (Haematoxylin & eosin, 40x).
![Parakeratosis, apoptosis, vacuolar degeneration (black arrowheads), superficial dermal oedema with superficial perivascular lymphoplasmacytic infiltration (Haematoxylin & eosin, 100x).](/content/126/2024/0/1/img/IJDVL_553_2024-g5.png)
- Parakeratosis, apoptosis, vacuolar degeneration (black arrowheads), superficial dermal oedema with superficial perivascular lymphoplasmacytic infiltration (Haematoxylin & eosin, 100x).
Dermatomyositis is an uncommon autoimmune inflammatory myopathy of unknown aetiology. Patients may present with heterogeneous symptoms that can make diagnosis challenging. Pathognomonic rashes of dermatomyositis include Gottron’s papules and heliotrope rash. Symmetrical proximal muscle weakness or elevated muscle enzyme levels may help with the diagnosis.
Flagellate erythema is rare in patients with dermatomyositis, affecting <5% of cases.3 This skin condition is characterised by violaceous parallel streaks, also known as ‘zebra stripes’, often observed along with erythematous plaques. A pronounced erythematous hue indicates intense inflammation and an active disease state, distinguishing it from a bleomycin-induced condition that typically manifests as brownish and hyperpigmented lesions.1 Histopathological findings are non-specific; epidermal atrophy, vacuolar interface dermatitis, dermal oedema, mucin deposition and perivascular lymphocytic infiltration have been described.4 The evidence from direct immunofluorescence is inconclusive and the findings are controversial. Though the exact aetiology remains unknown, it is presumed to be associated with physical injury, such as minor trauma or sun exposure. Mechanical stimuli from recurrent scratching may also be a significant factor since pruritus is a common symptom.1 There are reports of an association with pulmonary complications or a paraneoplastic aetiology, especially in men.5 Therefore, these patients should be closely monitored for occult malignancies.
The gold standard therapy is systemic corticosteroids (prednisolone 0.5–2 mg/kg/day) in combination with topical corticosteroids or calcineurin inhibitors.6,7 Symptom relief is generally expected within 4 weeks, followed by gradual dose tapering.7 The use of antimalarial drugs like hydroxychloroquine is not recommended since it has recently been suggested to cause flare-ups of cutaneous disease.6 Disease-modifying antirheumatic drugs such as methotrexate, azathioprine, or mycophenolate mofetil can be administered as second-line or steroid-sparing agents. Other treatment options include rituximab, intravenous immunoglobulins and calcineurin inhibitors.
We present this case because of its distinctive morphology and unusual manifestations which contribute to the clinical heterogeneity of dermatomyositis.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
References
- Dermatomyositis in 132 patients with different clinical subtypes: Cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm Venereol. 2002;82:48-51.
- [CrossRef] [PubMed] [Google Scholar]
- Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267-81.
- [CrossRef] [PubMed] [Google Scholar]
- Zebra stripes in dermatomyositis: Case report and review of flagellate erythema‐associated dermatomyositis. J Eur Acad Dermatol Venereol. 2016;31:e7-9.
- [CrossRef] [PubMed] [Google Scholar]
- Dermatomyositis: Diagnosis and treatment. J Am Acad Dermatol. 2020;82:283-96.
- [CrossRef] [PubMed] [Google Scholar]
- Dermatomyositis: an acute flare and current treatments. Clin Med Insights Case Rep. 2019;12:117954761985537.
- [CrossRef] [Google Scholar]